These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. UK tetanus guidelines for burns - Are they irrelevent? Walsh K Burns; 2019 Nov; 45(7):1726-1727. PubMed ID: 31358376 [No Abstract] [Full Text] [Related]
23. [Effectiveness of allogenic and xenogenic antitoxins in the active-passive prophylaxis of tetanus in an experiment]. Nazarchuk LV Fiziol Zh (1978); 1988; 34(4):98-101. PubMed ID: 3181517 [No Abstract] [Full Text] [Related]
24. Tetanus. Brown H JAMA; 1968 May; 204(7):614-6. PubMed ID: 5694490 [No Abstract] [Full Text] [Related]
25. Tetanus prophylaxis in the management of patients with acute wounds. Miyagi K; Shah AK J Plast Reconstr Aesthet Surg; 2011 Oct; 64(10):e267-9. PubMed ID: 21602113 [No Abstract] [Full Text] [Related]
26. [Some remarks on the prevention of tetanus]. Galazka A Wiad Lek; 1967 Dec; 20(24):2185-90. PubMed ID: 5584307 [No Abstract] [Full Text] [Related]
28. [Tetanus 1972]. Eckmann L Schweiz Rundsch Med Prax; 1972 Jan; 61(3):63-4. PubMed ID: 5013191 [No Abstract] [Full Text] [Related]
29. [Specific prophylaxis of tetanus]. Galazka A Przegl Epidemiol; 1968; 22(2):157-71. PubMed ID: 5669180 [No Abstract] [Full Text] [Related]
30. Tetanus or drug reaction? Mackler S; Moskowitz M Hosp Pract (Off Ed); 1989 Aug; 24(8):75-8, 81-2, 85-9. PubMed ID: 2504742 [No Abstract] [Full Text] [Related]
31. [Rapid evaluation of the state of tetanus immunity in wounded persons]. Galazka A; Bobrowska B; Sporzyńska Z Przegl Epidemiol; 1971; 25(4):477-88. PubMed ID: 5160065 [No Abstract] [Full Text] [Related]
32. Tetanus prophylaxis in our hospitals. Bourke GJ J Ir Med Assoc; 1967 Oct; 60(364):364-6. PubMed ID: 6065845 [No Abstract] [Full Text] [Related]
33. [Critical evaluation of tetanus prevention by means of tetanus antitoxin]. Galazka A; Kukiz T; Adamus J Pol Przegl Chir; 1968 Jul; 40(7):794-805. PubMed ID: 5678543 [No Abstract] [Full Text] [Related]
37. [Changes in anti-tetanus antibodies under sero-toxoid therapy. Study in 50 patients with tetanus]. Goulon M; Girard O; Grosbuis S; Desormeau JP; Capponi MF Nouv Presse Med; 1976 Mar; 5(13):847-50. PubMed ID: 1264625 [TBL] [Abstract][Full Text] [Related]
38. [Immunogenicity of tetanus toxoid used in conjunction with high doses of tetanus antitoxin]. Galazka A; Januszkiewicz J; Sporzyńska Z; Adamczyk J Przegl Epidemiol; 1974; 28(3):345-53. PubMed ID: 4409780 [No Abstract] [Full Text] [Related]
39. [Current status of preventive measures in tetanus]. Eckmann L Langenbecks Arch Chir; 1969; 325():937-40. PubMed ID: 4190266 [No Abstract] [Full Text] [Related]
40. The prevention of tetanus - the use of human antitetanus immunoglobulin. Drug Ther Bull; 1975 Sep; 13(20):77-9. PubMed ID: 1183316 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]